BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3038473)

  • 21. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action.
    Chu TC; Ogidigben MJ; Potter DE
    Exp Eye Res; 1999 Aug; 69(2):227-38. PubMed ID: 10433858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of [3H]-noradrenaline from the sympathetic nerves to bovine mesenteric lymphatic vessels and its modification by alpha-agonists and antagonists.
    Allen JM; McCarron JG; McHale NG; Thornbury KD
    Br J Pharmacol; 1988 Jul; 94(3):823-33. PubMed ID: 2902893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. M2-type muscarinic receptors mediate prejunctional inhibition of norepinephrine release in the human iris-ciliary body.
    Jumblatt JE; Hackmiller RC
    Exp Eye Res; 1994 Feb; 58(2):175-80. PubMed ID: 7512511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of adrenergic agents on transepithelial electrical measurements across the isolated iris-ciliary body.
    Krupin T; Wax MB; Carré DA; Moolchandani J; Civan MM
    Exp Eye Res; 1991 Dec; 53(6):709-16. PubMed ID: 1783009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha 2-adrenoceptor activation inhibits noradrenaline release in human and rabbit isolated renal arteries.
    Rump LC; Ruff G; Wolk V; Schollmeyer P
    Eur J Pharmacol; 1991 Apr; 196(3):277-83. PubMed ID: 1680052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of alpha 2-adrenoceptor binding sites in rabbit ciliary body membranes.
    Jin Y; Verstappen A; Yorio T
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2500-8. PubMed ID: 8163339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine.
    Russell KR; Potter DE
    J Pharmacol Exp Ther; 2001 Sep; 298(3):941-6. PubMed ID: 11504788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of uveal sympathetic neurotransmission by peroxides.
    Opere C; Tang L; Imler M; Kim J; Okoye M; Ohia S
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):842-7. PubMed ID: 9112979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha 2-adrenergic and VIP receptors in rabbit ciliary processes interact.
    Bausher LP; Gregory DS; Sears ML
    Curr Eye Res; 1989 Jan; 8(1):47-54. PubMed ID: 2565196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro determination of the ability of drugs to bind to adrenergic receptors.
    Neufeld AH; Page ED
    Invest Ophthalmol Vis Sci; 1977 Dec; 16(12):1118-24. PubMed ID: 200584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha 1-adrenergic receptor induced subsensitivity and supersensitivity in rabbit iris-ciliary body. Effects on myo-inositol trisphosphate accumulation, arachidonate release, and prostaglandin synthesis.
    Yousufzai SY; Abdel-Latif AA
    Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):409-19. PubMed ID: 3030953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes.
    Ogidigben MJ; Chu TC; Potter DE
    Pharmacology; 2002 Jul; 65(3):155-61. PubMed ID: 12037379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a physiological role of presynaptic alpha-adrenoceptors: modulation of noradrenaline release in the pithed rabbit.
    Majewski H; Hedler L; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):256-63. PubMed ID: 6141531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3H-Noradrenaline release from mouse iris-ciliary body: role of presynaptic muscarinic heteroreceptors.
    Bernhard M; Takeda K; Keller C; Haslebacher M; Lambrou GN; Trendelenburg AU
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):305-13. PubMed ID: 15375642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lisuride acts at multiple sites to induce ocular hypotension and mydriasis.
    Potter DE; Ogidigben MJ; Chu TC
    Pharmacology; 1998 Nov; 57(5):249-60. PubMed ID: 9742290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of norepinephrine release through alpha 1- and alpha 2-adrenoceptors in rat isolated kidney.
    Rump LC; Majewski H
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):500-7. PubMed ID: 2438514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prejunctional receptors and second messengers for angiotensin II in the rabbit iris-ciliary body.
    Ohia SE; Jumblatt JE
    Exp Eye Res; 1993 Oct; 57(4):419-25. PubMed ID: 8282027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examination of the role of inhibition of cyclic AMP in alpha 2-adrenoceptor mediated contractions of the porcine isolated palmar lateral vein.
    Wright IK; Harling R; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jan; 114(1):157-65. PubMed ID: 7712012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenergic receptor subtypes in rabbit iris-ciliary body membranes: classification by radioligand studies.
    Mittag TW; Tormay A
    Exp Eye Res; 1985 Feb; 40(2):239-49. PubMed ID: 2984032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.